实用肝脏病杂志2017，Vol.20Issue(1)：124-128,5.DOI:10.3969/j.issn.1672-5069.2017.01.035
慢性乙型肝炎抗病毒治疗新进展
Antiviral therapy for chronic hepatitis B
侯春艳(综述) 1杨永峰(审校)2
作者信息
- 1. 210000 南京市 东南大学医学院感染病学
- 2. 210000 南京市 东南大学附属第二医院肝病科
- 折叠
摘要
Abstract
Chronic hepatitis B is caused by hepatitis B viral infection. It is a systemic infections mainly including inflammation and necrosis lesions of liver. At present,antiviral drugs to treat hepatitis B mainly include two categories,e.g. interferon and nucleotide analogues. Now,scholars are exploiting new agents,the optimization of combination therapy,immune or apoptosis therapy to eradicate chronic HBV infection.关键词
慢性乙型肝炎/抗病毒治疗/进展Key words
Chronic hepatitis B/Antiviral therapy/Progress引用本文复制引用
侯春艳(综述),杨永峰(审校)..慢性乙型肝炎抗病毒治疗新进展[J].实用肝脏病杂志,2017,20(1):124-128,5.
